Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01085929 · ClinicalTrials.gov registry record · Phase 3

Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses

A Phase 3 study of Abscess and Cellulitis, sponsored by University of Massachusetts, Worcester.

Completed
Registry status
Phase 3
Development phase
101
Enrollment target
2
Study locations

NCT01085929: Completed Phase 3 study of Abscess and Cellulitis, sponsored by University of Massachusetts, Worcester.

NCT01085929 is a Phase 3 study of Abscess and Cellulitis that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 101 participants, below the 382-participant average among 13 other Abscess trials with a reported enrollment target (74% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01085929, a Phase 3 study of Abscess and Cellulitis, has completed, sponsored by University of Massachusetts, Worcester.

COMPLETED
Registry status
Phase 3
Development phase
101 participants
Enrollment target
2
Study locations

Study Summary

The incidence of skin and soft tissue infections has increased dramatically over the last decade, in part due to increased prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Incision and drainage (I\&D) is considered the primary intervention, however some clinicians prefer ultrasound guided needle aspiration (US Asp). The investigators performed a randomized trial comparing US Asp to I\&D for uncomplicated skin and soft tissue abscesses, with a subgroup analysis of patients with CA-MRSA.

Primary Outcome

Clinical outcome at 7 days

Conditions Studied

Interventions

  • PROCEDURE Incision and Drainage
  • PROCEDURE Ultrasound Guided Aspiration

Study Locations (2)

Massachusetts

  • Beth Isreal Deaconess Medical Center - Boston
  • University of Massachusetts - Worcester

Trial Details

FieldValue
Enrollment Target 101 participants
Start Date 2008-08
Est. Completion 2009-12
Phase Phase 3

What the finished NCT01085929 record still lists

NCT01085929 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 382-participant average among 13 other Abscess trials with a reported enrollment target (74% lower).

The record links to 2 conditions, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Incision and Drainage is the first listed.

NCT01085929 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT01085929 about?

NCT01085929 is a clinical study titled "Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses". The incidence of skin and soft tissue infections has increased dramatically over the last decade, in part due to increased prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA). Incision and drainage (I\&D) is considered the primary intervention, however some clinici...

What is the current status of trial NCT01085929?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 101 participants. The study started on 2008-08. Estimated completion is 2009-12.

What conditions does trial NCT01085929 study?

This clinical trial studies the following conditions: Abscess, Cellulitis.

What interventions are being tested in trial NCT01085929?

The interventions under investigation include: Incision and Drainage (PROCEDURE), Ultrasound Guided Aspiration (PROCEDURE).

Who is sponsoring clinical trial NCT01085929?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01085929 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abscess

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01085929's enrollment target sits among peer trials

101 8th of 13 higher than 6 of 13 other Abscess trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04033497 · 101 participants · NA

    Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases

  • NCT05111574 · 101 participants · Phase 2

    Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

  • NCT05984680 · 101 participants

    COPD Care Pathway Among Patients With Cancer

  • NCT06266299 · 101 participants · Phase 1

    A Study of KK2269 in Adult Participants With Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01085929, the US trial registry maintained by the National Library of Medicine. NCT01085929 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.